Palisade Bio(PALI)
$0.93-0.02 (-1.80%)
PALI
Palisade Bio financials statements
$0.93
At close:-0.02 (-1.80%)
Want to see PALI full AI Analyst Report?
Palisade Bio (PALI) Ratios
747 Followers
Palisade Bio Ratios
PALI's free cash flow for Q3 2026 was $-11.76M. For the 2026 fiscal year, PALI's free cash flow was increased by $0.00 and operating cash flow was $-11.76M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 28.95 | 3.24 | 5.15 | 4.89 | 4.61 |
| Quick Ratio | 28.95 | 3.24 | 5.15 | 4.89 | 4.61 |
| Cash Ratio | 28.77 | 3.03 | 4.81 | 4.11 | 4.20 |
| Solvency Ratio | -3.38 | -4.26 | -4.49 | -4.34 | -5.17 |
| Operating Cash Flow Ratio | -2.34 | -3.77 | -4.31 | -4.44 | -5.92 |
| Short-Term Operating Cash Flow Coverage | -152.77 | -154.34 | -70.46 | -151.82 | -169.80 |
| Net Current Asset Value | $ 129.26M | $ 7.11M | $ 10.59M | $ 11.45M | $ 6.36M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.02 | 0.03 | 0.03 | 0.02 |
| Debt-to-Equity Ratio | 0.00 | 0.02 | 0.03 | 0.03 | 0.03 |
| Debt-to-Capital Ratio | 0.00 | 0.02 | 0.03 | 0.03 | 0.03 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.04 | 1.45 | 1.24 | 1.26 | 1.70 |
| Debt Service Coverage Ratio | -207.01 | -158.49 | -70.99 | -141.03 | -9.74 |
| Interest Coverage Ratio | -1805.60 | -1238.25 | -871.33 | -1209.31 | -17.45 |
| Debt to Market Cap | 0.00 | 0.03 | 0.04 | 0.00 | 0.01 |
| Interest Debt Per Share | 0.00 | 0.13 | 0.84 | 0.47 | 209.22 |
| Net Debt to EBITDA | 7.95 | 0.67 | 0.98 | 0.84 | 0.43 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 100.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | -4914.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | -4912.40% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | -5228.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | -4920.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | -4920.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | -4920.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 92.94% | 97.17% | 94.11% | 90.71% | 63.59% |
| Return on Assets (ROA) | -12.49% | -132.70% | -87.53% | -90.47% | -212.72% |
| Return on Equity (ROE) | -12.97% | -192.71% | -108.72% | -114.27% | -361.38% |
| Return on Capital Employed (ROCE) | -13.92% | -194.39% | -113.99% | -123.29% | -417.87% |
| Return on Invested Capital (ROIC) | -13.91% | -190.18% | -111.28% | -121.45% | -409.73% |
| Return on Tangible Assets | -12.49% | -132.70% | -87.53% | -90.47% | -212.72% |
| Earnings Yield | -12.83% | -617.96% | -304.78% | -20.77% | -219.92% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 1.69 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 1.20 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 216.08 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 216.08 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 216.08 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.19 | -8.61 | -24.41 | -15.18 | -1190.12 |
| Free Cash Flow Per Share | -0.19 | -8.61 | -24.42 | -15.19 | -1190.12 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | -2783.25 | -1336.00 | 0.00 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | -2783.25 | -1336.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | -152.77 | -72.15 | -30.17 | -33.07 | -74.24 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | -44.53 | 0.00 | 0.00 |
| Free Cash Flow Yield | -8.29% | -521.87% | -275.96% | -19.48% | -122.06% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -7.83 | -0.16 | -0.33 | -4.81 | -0.45 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 16.14 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 1.01 | 0.31 | 0.36 | 5.50 | 1.64 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -12.06 | -0.19 | -0.36 | -5.13 | -0.82 |
| Price-to-Operating Cash Flow Ratio | -12.06 | -0.19 | -0.36 | -5.14 | -0.82 |
| Price-to-Earnings Growth (PEG) Ratio | 0.08 | 0.00 | -0.01 | 0.05 | -0.00 |
| Enterprise Value Multiple | 0.15 | 0.51 | 0.65 | -3.98 | -0.07 |
| Enterprise Value | -2.49M | -7.32M | -8.03M | 56.67M | 1.81M |
| EV to EBITDA | 0.15 | 0.51 | 0.65 | -3.98 | -0.07 |
| EV to Sales | 0.00 | 0.00 | -32.11 | 0.00 | 0.00 |
| EV to Free Cash Flow | 0.23 | 0.60 | 0.72 | -4.24 | -0.12 |
| EV to Operating Cash Flow | 0.23 | 0.60 | 0.72 | -4.24 | -0.12 |
| Tangible Book Value Per Share | 2.32 | 5.29 | 24.81 | 14.18 | 593.33 |
| Shareholders’ Equity Per Share | 2.32 | 5.29 | 24.81 | 14.18 | 593.33 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.55 | 0.00 | 0.00 |
| Net Income Per Share | -0.30 | -10.20 | -26.97 | -16.20 | -2144.20 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.10 |
| Research & Development to Revenue | 0.00 | 0.00 | 27.57 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 24.81 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 2.50 | 0.00 | 0.00 |
| Income Quality | 0.65 | 0.84 | 0.91 | 0.94 | 0.56 |
Currency in USD

